What the company does
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV, that is in phase 2 trial for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, England, Finland, Switzerland, Japan, Austria, Italy, Spain, Taiwan, …
What the weekly tape is saying
BAVA closed the latest completed week at 24.68 EUR. The 4-week return is -1.8% and the 12-week return is -2.6%. Trend Signal is inactive, Market Dynamics is -0.11. Setup signature: Risk-first tape with a 24/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 25.54 EUR
- Vs Trend Line
- -3.4%
- Fair Value
- 24.78 EUR
- Vs Fair Value
- -0.4%
- 52W High
- 32.52 EUR
- 52W Low
- 22.26 EUR
- Drawdown
- -24.1%
- Range Position
- 23.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 16
- 52W Active Breadth
- 30.8%
- Sector Scope
- AT Healthcare
- Sector Rank
- 24 of 112
- Sector Percentile
- 79.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 81 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Biotechnology
- Tracked Peers
- 21
- 4W Rank
- 13 of 21
- Avg 1W
- -2.5%
- Avg 4W
- 0.3%
- Trend Breadth
- 23.8%
- Positive RS
- 9.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.11
- 4W MD Change
- 22.7%
- Relative Strength
- -25.86
- 4W RS Change
- -24.4%
- Expectation
- Positive
- Probability
- 57.55%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 0
- 13W Average
- 56
- 52W Average
- 68
- Vs 13W
- -
- Vs 52W
- -
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.2%
- 52W Volatility
- 5.4%
- Upside Weeks
- 31
- Downside Weeks
- 19
- Downside Breadth
- 36.5%
- Avg Gain / Loss
- 2.5% / -3.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 1.9B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 24.68 EUR | 1.7% | 25.54 EUR | 24.78 EUR | -0.11 | -25.86 | 0 | Off |
| 5 Jun 2026 | 24.26 EUR | -3.2% | 25.51 EUR | 24.81 EUR | -0.00 | -25.50 | 0 | Off |
| 29 May 2026 | 25.06 EUR | -4.9% | 25.54 EUR | 24.83 EUR | 0.14 | -24.25 | 0 | Off |
| 22 May 2026 | 26.36 EUR | 4.9% | 25.77 EUR | 24.84 EUR | 0.09 | -18.45 | 0 | Off |
| 15 May 2026 | 25.14 EUR | -0.8% | 25.96 EUR | 24.83 EUR | -0.14 | -20.78 | 726 | Off |
| 8 May 2026 | 25.34 EUR | 1.0% | 26.19 EUR | 24.85 EUR | -0.08 | -20.66 | 1 | Off |
| 1 May 2026 | 25.10 EUR | 0.5% | 26.38 EUR | 24.87 EUR | 0.02 | -20.44 | 0 | Off |
| 24 Apr 2026 | 24.98 EUR | -6.6% | 26.57 EUR | 24.86 EUR | 0.13 | -20.50 | 0 | Off |
| 17 Apr 2026 | 26.74 EUR | 1.2% | 26.76 EUR | 24.86 EUR | 0.22 | -18.01 | 0 | Off |
| 10 Apr 2026 | 26.42 EUR | 1.6% | 26.90 EUR | 24.86 EUR | 0.08 | -17.18 | 0 | Off |
| 3 Apr 2026 | 26.01 EUR | 1.9% | 27.07 EUR | 24.86 EUR | -0.09 | -13.34 | 0 | Off |
| 27 Mar 2026 | 25.52 EUR | 0.7% | 27.26 EUR | 24.86 EUR | -0.19 | -12.07 | 7 | Off |
| 20 Mar 2026 | 25.34 EUR | 4.1% | 27.47 EUR | 24.87 EUR | -0.10 | -11.51 | 0 | Off |
| 13 Mar 2026 | 24.34 EUR | -0.3% | 27.67 EUR | 24.86 EUR | 0.12 | -16.18 | 0 | Off |